Point/Counterpoint: Stenting for idiopathic intracranial hypertension

JNIS Podcast

Content provided by BMJ Group. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BMJ Group or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

10M ago 32:22

MP3•Episode home

In this podcast, JNIS Editor-in-Chief, Dr. Felipe C. Albuquerque, speaks with Dr. Michael Levitt (1) and Dr. Colin Derdeyn (2), authors of a pair of editorials discussing the practice of dural venous sinus stenting for patients with idiopathic intracranial hypertension.

Point: Dural venous sinus stenting should be considered a first-line treatment option for select patients with idiopathic intracranial hypertension https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020597

Counterpoint: stenting for idiopathic intracranial hypertension should be trialed
https://jnis.bmj.com/content/early/2023/06/20/jnis-2023-020404

These articles are free-to-access for a month following the publication of this podcast.

Please subscribe to the JNIS Podcast via all podcast platforms, including Apple Podcasts, Google Podcasts, Stitcher and Spotify, to get the latest episodes. Also, please consider leaving us a review or a comment on the JNIS Podcast iTunes page: https://podcasts.apple.com/gb/podcast/jnis-podcast/id942473767

Thank you for listening! This episode was edited by Brian O'Toole.

(1) Neurological Surgery, University of Washington School of Medicine, Seattle, Washington, USA
(2) Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA

89 episodes

#Medicine #Aneurysm #Stroke #Vascular #Malformation #Brain #Spine #Treatment #Cost #Efficacy #BMJ Group #Fitness